Automated Suturing Devices Market is poised to expand at over 7.3% CAGR between 2022 and 2031

According to Future Market Insights, the global automated suturing devices is poised to expand at a CAGR of 7.3% to reach a valuation of approx. US$ 473 million through 2021 and beyond.

Increasing research & development for advanced automated suturing devices due to the rising adoption of minimally invasive procedure is anticipated to accelerate the demand across countries such as U.S., Japan, India, China and UK.

Automated Suturing Devices Market Key Highlights from Report

• [257 Pages Report] How will the automated suturing devices market grow in the forecast period of 2021 and 2031?According to FMI, the global automated suturing devices market is poised to expand at over 7.3% CAGR between 2021 and 2031.
• Which is the most lucrative automated suturing devices market?According to FMI, North America is expected to be the most lucrative region over the forecast period of 2021-2031. Within North America, the U.S. is expected to account for maximum sales.
• Who is the leading end user of automated suturing devices?Hospitals are expected to emerge as the leading end user in the automated suturing devices market.
• Which are the prominent automated suturing devices market players?Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the global automated suturing devices market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-579

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market across Asia Pacific excluding Japan (APEJ).

Rising preference for automated suturing devices over conventional ones during laparoscopic surgery is a major factor for market growth. Furthermore, the device is also preferred by procurement teams at hospitals as it’s labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices. Thereby, improving the market growth.

Major Key Companies Profiled:

• Medtronic Plc.
• Boston Scientific
• C. R. Bard, Inc.
• Apollo Endosurgery
• EndoEvolution, LLC
• LSI Solutions, Inc.
• SuturTek Inc.

Key Takeaways from FMI’s Automated Suturing Devices Market Study

• By product type, disposable automated suturing devices to emerge as lucrative segment through 2021
• Increasing application in minimally invasive surgeries to stimulate suturing devices sales
• The U.S. is expected to experience noteworthy expansion amid robust presence of regional suture devices manufacturers, experiencing 1.9x growth
• India and China are expected to offer lucrative opportunities across South Asia & East Asia
• Japan is expected to register a stellar growth on the back of rising adoption of minimally invasive procedures
• Growing cases of gastrointestinal diseases to widen automated suturing devices adoption across Germany

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-579

Competitive Landscape

Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the automated suturing devices market.

Product development and innovation of new devices coupled with strategic mergers and acquisition remains the core strategy for the leading players to maintain a strong foothold in the industry.

In December 2019, for instance, a global leading player, Advanced Medical Solutions Group PLC, manufacturer of tissue adhesives, sutures, hemostats, and internal fixation devices, announced the acquisition of Biomatlante, a developer of synthetic bone graft technologies.

In September 2019, another leading player, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for the use with the Over Stitch Endoscopic Suturing Systems.

Furthermore, in June 2018, Apollo Endosurgery, Inc. received Special 510(k) clearance from the U.S. Food and Drug Administration for Over Stitch Sx Endoscopic Suturing System. The endoscopic suturing systems allowed physicians to place full-thickness sutures from a flexible endoscope in endoscopic surgery.